These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22574652)

  • 1. Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications.
    Peters MF; Scott CW; Ochalski R; Dragan YP
    Assay Drug Dev Technol; 2012 Dec; 10(6):525-32. PubMed ID: 22574652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.
    Peters MF; Lamore SD; Guo L; Scott CW; Kolaja KL
    Cardiovasc Toxicol; 2015 Apr; 15(2):127-39. PubMed ID: 25134468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity.
    Lamore SD; Kamendi HW; Scott CW; Dragan YP; Peters MF
    Toxicol Sci; 2013 Oct; 135(2):402-13. PubMed ID: 23897988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An impedance-based cellular assay using human iPSC-derived cardiomyocytes to quantify modulators of cardiac contractility.
    Scott CW; Zhang X; Abi-Gerges N; Lamore SD; Abassi YA; Peters MF
    Toxicol Sci; 2014 Dec; 142(2):331-8. PubMed ID: 25237062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of drug-induced arrhythmic risk using limit cycle and autocorrelation analysis of human iPSC-cardiomyocyte contractility.
    Kirby RJ; Qi F; Phatak S; Smith LH; Malany S
    Toxicol Appl Pharmacol; 2016 Aug; 305():250-258. PubMed ID: 27343406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance beating pattern function of human induced pluripotent stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition.
    Hu N; Wang T; Wang Q; Zhou J; Zou L; Su K; Wu J; Wang P
    Biosens Bioelectron; 2015 May; 67():146-53. PubMed ID: 25153933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.
    Abassi YA; Xi B; Li N; Ouyang W; Seiler A; Watzele M; Kettenhofen R; Bohlen H; Ehlich A; Kolossov E; Wang X; Xu X
    Br J Pharmacol; 2012 Mar; 165(5):1424-41. PubMed ID: 21838757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment.
    Zhang X; Guo L; Zeng H; White SL; Furniss M; Balasubramanian B; Lis E; Lagrutta A; Sannajust F; Zhao LL; Xi B; Wang X; Davis M; Abassi YA
    J Pharmacol Toxicol Methods; 2016; 81():201-16. PubMed ID: 27282640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System.
    Xi B; Wang T; Li N; Ouyang W; Zhang W; Wu J; Xu X; Wang X; Abassi YA
    J Lab Autom; 2011 Dec; 16(6):415-21. PubMed ID: 22093298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of PatchXpress planar patch clamp technology to the screening of new drug candidates for cardiac KCNQ1/KCNE1 (I Ks) activity.
    Trepakova ES; Malik MG; Imredy JP; Penniman JR; Dech SJ; Salata JJ
    Assay Drug Dev Technol; 2007 Oct; 5(5):617-27. PubMed ID: 17939752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.
    Guo L; Coyle L; Abrams RM; Kemper R; Chiao ET; Kolaja KL
    Toxicol Sci; 2013 Dec; 136(2):581-94. PubMed ID: 24052561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New easy-to-use hybrid system for extracellular potential and impedance recordings.
    Doerr L; Thomas U; Guinot DR; Bot CT; Stoelzle-Feix S; Beckler M; George M; Fertig N
    J Lab Autom; 2015 Apr; 20(2):175-88. PubMed ID: 25532527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved throughput of PatchXpress hERG assay using intracellular potassium fluoride.
    Zeng H; Penniman JR; Kinose F; Kim D; Trepakova ES; Malik MG; Dech SJ; Balasubramanian B; Salata JJ
    Assay Drug Dev Technol; 2008 Apr; 6(2):235-41. PubMed ID: 18471077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity.
    Rajasingh S; Isai DG; Samanta S; Zhou ZG; Dawn B; Kinsey WH; Czirok A; Rajasingh J
    Acta Pharmacol Sin; 2018 Oct; 39(10):1590-1603. PubMed ID: 29620051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
    Guo L; Guthrie H
    J Pharmacol Toxicol Methods; 2005; 52(1):123-35. PubMed ID: 15936217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity.
    Sirenko O; Cromwell EF; Crittenden C; Wignall JA; Wright FA; Rusyn I
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):500-7. PubMed ID: 24095675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
    Clements M; Millar V; Williams AS; Kalinka S
    Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.